Insights


Case Based Insights: Expert Perspectives on the Treatment of Adult-Onset SMA

July 21st 2021

A key opinion leader in neurology, Arun S. Varadhachary, MD, PhD, reviews the case of a 28-year-old with spinal muscular atrophy and considers the role of nusinersen for patients with later-onset SMA.

Treatment of Rare Systemic Autoimmune Rheumatic Diseases (SARDS): Systemic Lupus Erythematous (SLE) and Idiopathic Inflammatory Myopathies

June 7th 2021

Expert rheumatologist, Kostas N. Botsoglou, MD provides an overview of the current therapeutic landscape for Systemic Autoimmune Rheumatic Diseases (SARDs) and discusses potential treatments on the horizon.

Cardiovascular Risk Management in Patients With Diabetes

June 4th 2021

Drs Marc P. Bonaca and Manesh R. Patel discuss the role of antiplatelet and anticoagulating agents in the treatment of patients with concurrent type 2 diabetes as per the 2021 ADA Standards of Medical Care in Diabetes.

Optimal Management of Opioid Induced Constipation

June 3rd 2021

Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, review currently available treatment options for the management of opioid-induced constipation.

A Review of Treatment Options for the Management of Sickle Cell Disease

May 24th 2021

Michael R. DeBaun, MD, MPH, reviews the use of recent FDA-approved therapies along with the conventional treatment options for the management of sickle cell disease.

Advances in the Management of Age-Related Macular Degeneration

April 20th 2021

Recommendations for appropriate selection and use of anti-VEGF therapy for age-related macular degeneration to reduce treatment burden.

Expert Perspectives on the Clinical Impact of Non-Medical Therapeutic Switching

March 19th 2021

Adam Friedman, MD, FAAD provides insight into how and why insurance companies implement non-medical therapeutic switching and what healthcare providers can do to mitigate its impact on patient care.

Optimal Management of ADHD

March 12th 2021

Andrew J. Cutler, MD, and Rakesh Jain, MD, MPH, discuss current and emerging therapies for the management of attention deficit hyperactivity disorders (ADHD).

Cure SMA: Evaluation of SMA in the Era of Telehealth

March 11th 2021

The HCPLive Insights series, “Evaluation of Spinal Muscular Atrophy in the Era of Telehealth,” put on in partnership with Cure SMA, features Diana Castro, MD, and Garey H. Noritz, MD, who offer tips and demonstrations for screening and diagnosing SMA via telehealth. Additionally, resources provided by Cure SMA are outlined for families and clinicians who suspect SMA or have a patient diagnosed with SMA.

Institution-Focused Management of Schizophrenia

March 8th 2021

Henry Nasrallah, MD, provides insight on the optimal management of schizophrenia including the use of LAIs.